Though its history is one fraught with lessons and lawsuits, the drug's legacy, in the end, is and will be one of human health and some mercy for millions afflicted with HIV/AIDS.

Revenues from Ziagen has so far brought the U about $500 million, providing positions for faculty and fellowships for graduate students and postdoctoral fellows, and for the ongoing work of the center and its scientists, current and becoming, who will, like Vince, make discoveries that will continue to improve the world, through the lens of science, for years to come.